medigraphic.com
Instituto Nacional de Salud Pública

2024, Number 1

<< Back

salud publica mex 2024; 66 (1)

Implementation of a population-based cancer registry network in Mexico 2017-2020

Mohar A, Paredes A, Brau-Figueroa H, Sánchez A, Palafox A, Rivera-Gómez R, Pech K, Carranza-Matus M, Arrieta O, Inchaustegui A, Moreno E, Piñeros M

Language: English
References: 31
Page: 104-112
PDF size: 426.19 Kb.


ABSTRACT

The growing cancer burden particularly among less developed countries requires local data to plan and evaluate cancer control measures. This article describes the development of a population-based cancer registry network (PBCRN) in Mexico that took place between 2017 and 2020 and present related data. The PBCRN, led by the National Cancer Institute (Incan), included nine registries representing 11.3% of the Mexican population. Definitions, coding, and operative processes were based on international standards. All cities were visited to set up local structure; personnel were hired by Incan and trained in basic cancer registration in Merida. A specific software was developed. Regular virtual meetings took place for data verification and quality control. Data collection included institutions of the public and private health system. Personnel included 34 registrars, nine local leaders, and 12 staff members at the Incan. A total of 13 517 cases were recorded between 2017-2020, 64% percent of them were among females. Breast cancer was the more frequent malignancy (23.3%), followed by digestive organs with (18.4%) and female genital cancers (13.5%). Childhood (0-14 years) and adolescents cancer represented 4.4% of the total new cancer cases. The network was suspended in 2020. The present effort lacked sustainability and data were only partial. However, the experience provides valuable insights to be considered for the renewed cancer registration efforts that are currently ongoing in Mexico.


REFERENCES

  1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, PiñerosM, et al. Estimating the global cancer incidence and mortality in 2018:GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-53.https://doi.org/10.1002/ijc.31937

  2. Soerjomataram I, Bray F. Planning for tomorrow: global cancerincidence and the role of prevention 2020-2070. Nat Rev Clin Oncol.2021;18(10):663-72. https://doi.org/10.1038/s41571-021-00514-z

  3. Leal YA, Torres J, Gamboa R, Mantilla-Morales A, Piña-Sanchez P, ArrietaO, et al. Cancer Incidence in Merida, Mexico 2015-2018: First Report fromthe Population-based Cancer Registry. Arch Med Res. 2022;53(8):859-66.https://doi.org/10.1016/j.arcmed.2022.11.015

  4. Instituto Nacional de Estadística y Geografía. Características de lasdefunciones registradas en México durante 2017. Comunicado de prensanúm. 525/18. México: Inegi [cited Oct 16, 2022]. Available from: https://www.inegi.org.mx/contenidos/programas/mortalidad/doc/defunciones_registradas_2017_nota_tecnica.pdf

  5. Meneses-García A, Ruiz-Godoy LM, Beltrán-Ortega A, Sánchez-Cervantes F, Tapia-Conyer R, Mohar A. Principales neoplasias malignasen México y su distribución geográfica (1993-2002). Rev Invest Clin.2012;64(4):322-9. [cited Oct 16, 2022]. Available from: https://www.medigraphic.com/pdfs/revinvcli/nn-2012/nn124b.pdf

  6. Fajardo-Gutiérrez A, González-Miranda G, Pachuca-Vázquez A, Allende-López A, Fajardo-Yamamoto LM, Rendón-Macías ME. Cancer incidenceand mortality in children in the Mexican Social Security Institute (1996-2013). Salud Publica Mex. 2016;58(2):162-70. https://doi.org/10.21149/spm.v58i2.7785

  7. Secretaría de Salud. Plan Sectorial De Salud. Cáncer en la Infancia y laAdolescencia 2013-2018. México: Secretaría de Salud, 2014 [cited Nov 22,2022]. Available from: http://www.ssch.gob.mx/rendicionCuentas/archivos/Cancer%20en%20la%20Infancia%20y%20la%20Adolescencia.pdf

  8. Secretaría de Salud de Jalisco. Registro estatal de cáncer en Jalisco.México: Secretaría de Salud de Jalisco [cited May 10, 2023]. Availablefrom: https://ssj.jalisco.gob.mx/salud-publica/registros-estatales-de-salud/registro-estatal-de-cancer-en-jalisco

  9. Leal YA, Reynoso-Noverón N, Aguilar-Castillejos LF, Meneses-García A,Mohar A, Piñeros M. Implementation of the population-based cancer registryin the city of Mérida, Mexico: process and early results. Salud PublicaMex. 2019;62(1):96-104. https://doi.org/10.21149/10501

  10. Instituto Nacional de Cancerología. Programa Integral de Prevencióny Control de Cáncer en México. México: Incan, 2016 [cited May 10, 2023].Available from: https://www.iccpportal.org/system/files/plans/PICCM_FINALIncan_Enero2018.pdf

  11. Secretaría de Gobernación. Decreto por el que se reforman y adicionandiversas disposiciones de la Ley General de Salud. México: DiarioOficial de la Federación, 22 de junio de 2017 [cited May 10, 2023]. Availablefrom: https://www.dof.gob.mx/nota_detalle.php?codigo=5487731&fecha=22/06/2017#gsc.tab=0

  12. Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, et al.Planning and developing population-based cancer registration in low- ormiddle-income settings. Lyon, France: International Agency for Researchon Cancer, 2014;(43):1-46 [cited Mar 10, 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK566957/

  13. Fritz AP C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM,Whelan S. Clasificación Internacional de Enfermedades para Oncología(CIE-O). Washington, DC: Organización Panamericanade la Salud/Organización Mundial de la Salud, 2003 [cited May10, 2023]. Available from: https://apps.who.int/iris/bitstream/handle/10665/96612/9789241548496_eng.pdf

  14. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. InternationalClassification of Childhood Cancer, 3rd ed. Cancer. 2005;103(7):1457-67.https://doi.org/10.1002/cncr.20910

  15. Giraldo P, Latre P, Franco-García E, Alvarez R, Pascual M, Castilla T, etal. HAEMACARE Project: Reclassifing Hematologic Neoplasias AccordingMorphological Data. Blood. 2007;110(11):4392. https://doi.org/10.1182/blood.v110.11.4392.4392

  16. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification ofmalignant tumors, 8th ed. Chichester: John Wiley & Sons, 2017.

  17. International Agency for Research in Cancer. Global Initiative for CancerRegistry Development. IARC Regional Hubs for Cancer Registration.Geneva: WHO [cited May 10, 2023]. Available from: https://gicr.iarc.fr/

  18. Working Group of the International Association of Cancer Registries.Guidelines on confidentiality for population-based cancer registration.Eur J Cancer Prev. 2005;14(4):309-27. https://doi.org/10.1097/00008469-200508000-00003

  19. Congreso de la Ciudad de México. Ley de Protección de DatosPersonales en Posesión de Sujetos Obligados en la Ciudad de México.México: Gobierno Federal de los Estados Unidos Mexicanos, 11 defebrero de 2021, México [cited May 10, 2023]. Available from: https://www.congresocdmx.gob.mx/media/documentos/a8b6a4657686ea6f01e7a-024377b814e0664d634.pdf

  20. European Network of Cancer Registries. Development/recommendationson cancer registration standards: coding incidence date. France:ENCR [cited Oct 28, 2022]. Available from: https://www.encr.eu/

  21. Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalenceestimates based on tumor registry data in the Surveillance, Epidemiology,and End Results (SEER) Program. Int J Epidemiol. 2000;29(2):197-207.https://doi.org/10.1093/ije/29.2.197

  22. Chatterjee S, Chattopadhyay A, Senapati SN, Samanta DR, Elliott L,Loomis D, et al. Cancer Registration in India - Current Scenario andFuture Perspectives. Asian Pac J Cancer Prev. 2016;17(8):3687-96.

  23. Omonisi AE, Liu B, Parkin DM. Population-based cancer registrationin Sub-Saharan Africa: its role in research and cancer control. JCO GlobOncol. 2020;6:1721-8. https://doi.org/10.1200/GO.20.00294

  24. Piñeros M, Laversanne M, Barrios E, de Camargo Cancela M, deVries E, Pardo C, et al. An updated profile of the cancer burden, patternsand trends in Latin America and the Caribbean. Lancet Reg Health Am.2022;13. https://doi.org/10.1016/j.lana.2022.100294

  25. Piñeros M, Abriata MG, Mery L, Bray F. Cancer registration forcancer control in Latin America: a status and progress report. RevPanam Salud Publica. 2017;41. Available from: https://iris.paho.org/handle/10665.2/33832

  26. Frech S, Muha CA, Stevens LM, Trimble EL, Brew R, Perin DP, et al. Perspectiveson strengthening cancer research and control in Latin Americathrough partnerships and diplomacy: experience of the National CancerInstitute’s Center for Global Health. J Glob Oncol. 2018;4:1-11. https://doi.org/10.1200/JGO.17.00149

  27. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, etal. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidenceand Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer JClin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660

  28. Muñoz-Aguirre P, Huerta-Gutierrez R, Zamora S, Mohar A, Vega-VegaL, Hernández-Ávila JE, et al. Acute lymphoblastic leukaemia survival inchildren covered by Seguro Popular in Mexico: a national comprehensiveanalysis 2005-2017. Health Syst Reform. 2021;7(1):1-10. https://doi.org/10.1080/23288604.2021.1914897

  29. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, BrayF, et al. International incidence of childhood cancer, 2001-10: a populationbasedregistry study. Lancet Oncol. 2017;18(6):719-31. https://doi.org/10.1016/S1470-2045(17)30186-9

  30. Rivera-Luna R, Perez-Vera P, Galvan-Diaz C, Velasco-Hidalgo L, Olaya-Vargas A, Cardenas-Cardos R, et al. Triple-hit explanation for the worseprognosis of pediatric acute lymphoblastic leukemia among Mexicanand Hispanic children. Front Oncol. 2022;12. https://doi.org/10.3389/fonc.2022.1072811

  31. Anane-Sarpong E, Wangmo T, Ward CL, Sankoh O, Tanner M, ElgerBS. “You cannot collect data using your own resources and put It onopen access”: Perspectives from Africa about public health data-sharing.Dev World Bioeth. 2018;18(4):394-405. https://doi.org/10.1111/dewb.12159




2020     |     www.medigraphic.com